METFORMIN AND INTESTINAL GLUCOSE HANDLING

[21] Kessler M, Meier W, Storelli C, Semenza G, The biguamde inhibition of D‐glucose transport in membrane vesicles from small intestine brush borders, Biochim Biophys Acta, 413, pp. 444-452, (1975)

[22] Mainguet P, Lauvaux JP, Franchkson JRM, Study of intestinal glucose absorption in diabetic patients after acute administration of dimethylbiguanide, Le Diabete, 20, pp. 39-42, (1972)

[23] Fossati P, Fontaine P, Beuscart R, Romon M, Bourdelle-Hego MF, LePoutre-Vaast D, Escape of non insulin dependent diabetes (NIDD) to the oral hypoglycemic agents control, Rev Franc Endocrinol Clin, 26, pp. 105-116, (1985)

[24] Jackson RA, Hawa MI, Jaspan JV, Sim BM, Disilvio L, Featherbe D, Kurtz AB, Mechanisms of metformin action in non‐insulin dependent diabetes, Diabetes, 36, pp. 632-640, (1987)

[25] Bailey CJ, Flatt PR, Ewan C, Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice, Arch Int Pharmacodyn Ther, 282, pp. 233-239, (1986)

[26] Hermann LS, Metformin: a review of its pharmacological properties and therapeutic use, Diabete Metab, 5, pp. 233-245, (1979)

[27] Bailey CJ, Flatt PR, Wilcock C, Day C, Antihyperglycaemic mechanism of action of metformin, Lessons from Animal Diabetes, 3, pp. 277-282, (1991)

[28] Leatherdale BA, Bailey CJ, Acute antihyperglycaemic effect of metformin without alteration of gastric emptying, IRCS Med Sci, 14, pp. 1085-1086, (1986)

[29] Gyr N, Berger W, Fridrich R, Denes A, Stalder GA, Der Einfluss von Dimethylbiguanid auf die Magentleerung und die orale Glukosetoleranz, Schweiz Med Wocherschr, 101, pp. 1876-1879, (1971)

[30] Hopfer U, Membrane transport mechanisms for hexoses and amino acids in the small intestine, Physiology of the Gastrointestinal Tract, pp. 1499-1526, (1987)

[21] Kessler M, Meier W, Storelli C, Semenza G, The biguamde inhibition of D‐glucose transport in membrane vesicles from small intestine brush borders, Biochim Biophys Acta, 413, pp. 444-452, (1975)

[22] Mainguet P, Lauvaux JP, Franchkson JRM, Study of intestinal glucose absorption in diabetic patients after acute administration of dimethylbiguanide, Le Diabete, 20, pp. 39-42, (1972)

[23] Fossati P, Fontaine P, Beuscart R, Romon M, Bourdelle-Hego MF, LePoutre-Vaast D, Escape of non insulin dependent diabetes (NIDD) to the oral hypoglycemic agents control, Rev Franc Endocrinol Clin, 26, pp. 105-116, (1985)

[24] Jackson RA, Hawa MI, Jaspan JV, Sim BM, Disilvio L, Featherbe D, Kurtz AB, Mechanisms of metformin action in non‐insulin dependent diabetes, Diabetes, 36, pp. 632-640, (1987)

[25] Bailey CJ, Flatt PR, Ewan C, Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice, Arch Int Pharmacodyn Ther, 282, pp. 233-239, (1986)

[26] Hermann LS, Metformin: a review of its pharmacological properties and therapeutic use, Diabete Metab, 5, pp. 233-245, (1979)

[27] Bailey CJ, Flatt PR, Wilcock C, Day C, Antihyperglycaemic mechanism of action of metformin, Lessons from Animal Diabetes, 3, pp. 277-282, (1991)

[28] Leatherdale BA, Bailey CJ, Acute antihyperglycaemic effect of metformin without alteration of gastric emptying, IRCS Med Sci, 14, pp. 1085-1086, (1986)

[29] Gyr N, Berger W, Fridrich R, Denes A, Stalder GA, Der Einfluss von Dimethylbiguanid auf die Magentleerung und die orale Glukosetoleranz, Schweiz Med Wocherschr, 101, pp. 1876-1879, (1971)

[30] Hopfer U, Membrane transport mechanisms for hexoses and amino acids in the small intestine, Physiology of the Gastrointestinal Tract, pp. 1499-1526, (1987)